Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 354.26M P/E - EPS this Y 15.60% Ern Qtrly Grth -
Income -62.26M Forward P/E -9.21 EPS next Y 42.10% 50D Avg Chg -3.00%
Sales 163.91M PEG - EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 11.78 EPS next 5Y - 52W High Chg -16.00%
Recommedations 1.50 Quick Ratio 1.17 Shares Outstanding 140.45M 52W Low Chg 166.00%
Insider Own 3.95% ROA -8.25% Shares Float 134.19M Beta 1.11
Inst Own 44.66% ROE -324.20% Shares Shorted/Prior 8.98M/9.64M Price 2.58
Gross Margin 82.52% Profit Margin -37.98% Avg. Volume 1,188,125 Target Price 4.75
Oper. Margin -22.17% Earnings Date Mar 6 Volume 669,522 Change -4.09%
About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

Xeris Biopharma Holdings, Inc. News
06:24 AM Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
04/05/24 Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
04/03/24 Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/02/24 Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/09/24 Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
03/07/24 Xeris Biopharma Holdings Inc (XERS) Reports Robust Revenue Growth in Q4 and Full Year 2023
03/07/24 Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
03/06/24 Q4 2023 Xeris Biopharma Holdings Inc Earnings Call
03/06/24 Xeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
03/06/24 Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
03/06/24 Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
03/05/24 Why Xeris (XERS) Might Surprise This Earnings Season
02/28/24 Xeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024
02/05/24 Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference
01/11/24 Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
01/10/24 Xeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of Teprotumumab
01/08/24 7 Small-Cap Stocks to Best Position Your Portfolio for a Strong 2024
01/04/24 Xeris Biopharma Updates Its Outlook for 2023
12/27/23 Xeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
12/23/23 11 High Growth Micro-Cap Stocks to Buy
XERS Chatroom

User Image joeykool Posted - 3 hours ago

$XERS im as bullish as the next guy but it looks like rate cuts are further off than expected, market topping, money going to defensive stocks and safe havens, xers is due for an earnings miss, PRs never seem to result in any meaningful stock gain, mgmt for sure is not buying under these circumstances, could we see a capitulation day ? Yes! Likely with next esrnings. Imo i dont see any more than $3.50, buyout or not, im holding for that number, i cant put my money under the mattress, my wife would find it...

User Image HorizonBull Posted - 4 hours ago

$XERS keep and add. This will back to 3+. golden oppiortunity toadd

User Image goodluck2all Posted - 4 hours ago

$XERS yes bullish RSI is @27😆😀 why not a pop to 1.90s?

User Image Venecia Posted - 4 hours ago


User Image therealpoub Posted - 5 hours ago

$XERS Jeff says 5-7 years. Looks like we have a few more to go my friends. https://x.com/stockmktnewz/status/1780428787550699743?s=46&t=HWbBKPyss-rwb10Q-j-lIA

User Image Brodman Posted - 5 hours ago

$XERS $3.18 March 1, March 15 $2.15, April 1 $2.09, April 17 $1.78.... What ahead - May 1 $1.50, June 1 UNDER $1.00!! Just wait until XERS doesn't meet the poor guidance numbers next earning period. Paul's strongest asset (besides spending) - destroying shareholder value!!

User Image goodluck2all Posted - 5 hours ago

$XERS can imagine mass layoffs and inflation together? will crash the economy that’s exactly what is going to happen after elections and Feds wants to see that to cut interest rates that take us deeper recession for years.

User Image hashemtrade Posted - 6 hours ago

$XERS now listen up. Nothing is stopping this company from growing to a billion $ annual revenue before 2030. With the current revenue growth rate of ca. 50 mil $ we would need 16 years but new product releases, cooperations and Europe Gvoke will

User Image Brodman Posted - 6 hours ago

$XERS Chances of this getting to $4.50 later this year is ZERO. XERS will have a hard time getting back to $2 later this year!! Paul full of BS!!

User Image Nizmeister Posted - 7 hours ago

$XERS potential upcoming PRs for 2024 so far that I can think of 1. Levo phase 2 topline data (1-2 months) 2. Tepezza trial initiation/update (anytime) 3. Regeneron milestone payment/license agreement (3-6 months) 4. Upward tightening of guidance (2-3 months) 5. New collaboration? (Anytime)

User Image xersdave Posted - 7 hours ago

$XERS well well well, we find ourselves in yet another test of ball size. Im calling DeJaVu. XERS rollercoaster and will be back up later this year. Why? Cuz even though Paul doesnt hsbe the rico suave social tongue, hes hungry to show the wotkd hes got the juice. Itll happen, time is all we meed to remrmber. WATCH. See you at $4.50 Oct 2nd.

User Image MarketILF Posted - 7 hours ago

$XERS Dear Fellow longs, please let me understand. Paul has been doing the CEO for years and knows how the market reacts. During the last ER he lowers the revenue forecast, says he might buy another company (and dilute…), and says Kev is suffering significant competition from generics. A man with his experience certainly knew how the market would react to his words, nobody can convince me that he did not know. So, my question is, why did he do that? 🤷‍♂️ Negative or positive we’ll see in the next few months. Any thoughts?

User Image APIS_BULL Posted - 8 hours ago

$XERS I feel we are all turning into bots lol - that’s the xers effect. Price tanks so nothing left, just pure speculation

User Image APIS_BULL Posted - 8 hours ago


User Image Alon_R Posted - 9 hours ago

$XERS Status & set up is absolutely great! And we have to respect Paul Edick's vision In a matter to create that good setup(and it explains why he said we'll reach 40-50$)! Now, saying that, It's only on Paul to provide good guidance Q1. As previous guidance was the first one I didn't like, because you dont mention that you might have think of purchasing other entity before you have sufficient profits/income to pay for that(especially after you already Stonebridged people). that was his mistake. Zuckerberg made mistake, Elon as well, so its ok. But that cost us this drop. I believe Paul is not the one to repeat mistakes. Because Xeris has all the ingredients! Growing drugs Growing Xeriject And Levo in progressed stage And the above combined sufficient to reach very nice profitability and revenue from $400M to who knows how much, as Halozyme(based of same S.O.) Now, if Paul knows something about huge Regeneron income of lets say $200M. Take that money and buy strong drug/company

User Image Sparky202 Posted - 10 hours ago

$XERS There is no "failure." There are two raging wars which affect global politics and economy (especially oil prices), interest rate cuts may be delayed, and XERS is in their slow quarter for Gvoke sales. Gvoke and Recorlev will continue to grow, even if Keveyis slows a bit. This fall will be record sales for Gvoke back to school. SubQ Levo will happen, and 2 collabs are happening with more on the way. Milestone payments and royalties will also keep growing. Its all about your time horizon. I have plenty of time and plenty of shares. This will be amazing. Cheers!

User Image SagehenNed Posted - 10 hours ago

$XERS I don’t think Paul is a bad guy, he’s just made some poor business decisions. And, unfortunately, he’s unwilling to admit his mistakes. This is where a strong and active BOD would come in handy, but they seem to be entirely passive.

User Image SagehenNed Posted - 10 hours ago

$XERS unfortunately Paul’s strategy/vision for the company has failed. The SBBP acquisition was overpriced and resulted in massive dilution. He seriously misled investors last year with his constant “we’ll be CF positive in the 4Q” mantra only to drop a bomb and announce a $50 million burn in 2024. They’re at an almost $200 million annual revenue number but are still miles away from making money. And to add insult to injury, he’s talking about making another acquisition. No wonder the stock has been cut in half.

User Image UncleRicoQB1 Posted - 10 hours ago

$XERS Is this a good stock?

User Image mcube1820 Posted - 10 hours ago

@UncleRicoQB1 "CEO Edick working hard to destroy $XERS shareholder value." Mission accomplished!

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS up 4 cents from 1.75 bottom. Perhaps CEO Edick is buying $millions of shares on the open market???

User Image UncleRicoQB1 Posted - 11 hours ago

$50...hilarious. Everyone shareholder should be ecstatic for a $5 offer given the shit show that $XERS CEO Edick has created here.

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS @TymeTryethTroth Agree $5-6 would be more appropriate. But big pharma could make the offer public after acquiring no more than 10% of the shares on the open market. Share price wouldn't move that much. Then CEO Edick and the Board would be put in a very tough spot once the offer became public. Are there any recent examples where companies rejected buyout offers for 100% to 200% above current share price?

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS Another day, another (negative) dollar. CEO Edick working hard to destroy $XERS shareholder value.

User Image Ithaca2018 Posted - 11 hours ago

$XERS Added a few, $1.76

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS Big pharma should proceed with a hostile takeover for $3-$4 per share, leak the buyout offer to the press, and force Edick and the Board's hand to accept it to avoid lawsuits from $XERS shareholders.

User Image BarbarianTrades Posted - 11 hours ago

$XERS monthly chart looks like it’s put in a trading range of 1.25 to 3. Monthly looks really bad with double top M pattern formed. Need to close April above 1.85-1.90

User Image Brodman Posted - 11 hours ago

$XERS This will be the 7th straight week that XERS has been RED for the week!! The death spiral continues, getting trashed again with no end in sight. $1 next stop!!

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS -25% year to date

User Image UncleRicoQB1 Posted - 11 hours ago

$XERS 3.26 to 1.76 since March 1. My paper loss at $359K and counting.

Analyst Ratings
Oppenheimer Outperform Mar 28, 24
HC Wainwright & Co. Buy Mar 7, 24
HC Wainwright & Co. Buy Nov 13, 23
Piper Sandler Overweight Nov 10, 23
Craig-Hallum Buy Aug 28, 23
HC Wainwright & Co. Buy Aug 9, 23
HC Wainwright & Co. Buy May 10, 23
HC Wainwright & Co. Buy Mar 9, 23
SVB Leerink Outperform Jan 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schmid John P. Director Director Nov 16 Buy 1.51 6,500 9,815 6,500 11/17/23
Shannon John Patrick Jr See Remarks See Remarks Nov 17 Buy 1.638 30,769 50,400 1,408,575 11/17/23
Edick Paul R See Remarks See Remarks Aug 09 Buy 2.3794 10,000 23,794 2,288,064 08/09/23